NOD2 deficiency exacerbates hypoxia-induced pulmonary hypertension and enhances pulmonary vascular smooth muscle cell proliferation. 2018

Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
School of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan, South Korea.

Expression of nucleotide-binding oligomerization domain protein 2 (NOD2) is upregulated in pulmonary artery smooth muscle cells (PASMCs) during hypoxia. To investigate the involvement of NOD2 in the pulmonary vascular response to hypoxia, we subjected wild-type and NOD2-deficient mice to chronic normobaric hypoxic conditions. Compared to wild-type mice, NOD2-deficient mice developed severe pulmonary hypertension with exaggerated elevation of right ventricular systolic pressure, profound right ventricular hypertrophy and striking vascular remodeling after exposure to hypoxia. Pulmonary vascular remodeling in NOD2-deficient mice was characterized by increased PASMC proliferation. Furthermore, hypoxia-inducible factor-1α expression and Akt phosphorylation were upregulated in PASMCs from NOD2-deficient mice exposed to hypoxia. Our findings revealed that the absence of NOD2 exacerbated hypoxia-induced PASMC proliferation, pulmonary hypertension and vascular remodeling, but had no effect on PASMC migration or contractility.

UI MeSH Term Description Entries

Related Publications

Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
August 2020, Journal of physiology and biochemistry,
Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
April 2008, Circulation,
Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
May 2007, The European respiratory journal,
Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
March 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
December 2023, Clinical and experimental hypertension (New York, N.Y. : 1993),
Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
November 2018, Cellular signalling,
Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
February 2024, GeroScience,
Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
February 2014, American journal of respiratory and critical care medicine,
Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
January 2018, Cardiovascular research,
Min-Young Kwon, and Narae Hwang, and Young-Jun Park, and Mark A Perrella, and Su Wol Chung
September 2015, European review for medical and pharmacological sciences,
Copied contents to your clipboard!